Novel 99m Tc-Labeled Mannose Derivative as a Highly Promising Single Photon Emission Computed Tomography Probe for Tumor Imaging
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c01425 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Guangxing Yin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Radiopharmaceuticals of Ministry of Education, NMPA (National Medical Products Administration) Key Laboratory for Research and Eval…. Hauptthemen laut MEDLINE: Mannose, Radiopharmaceuticals, Technetium, Tomography, Emission-Computed, Single-Photon. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Beijing Municipal Natural Science Foundation, National Natural Science Foundation of China, Beijing Nova Program.
Abstract (Originalsprache)
18F-2-fluoro-2-deoxy-d-glucose ([18F]FDG) has been the most used positron emission tomography imaging agent for clinical applications. Single photon emission computed tomography (SPECT) imaging is cheaper and used more widely for diagnostic use, but there is no SPECT tumor imaging agent for clinical applications comparable to [18F]FDG. Mannose is a C2 epimer of glucose and can also be transported into tumor cells via glucose transporters (GLUTs). To develop a novel SPECT tumor imaging agent with satisfactory tumor uptake and tumor/nontarget ratios, here a mannose derivative (CN7DM) was synthesized and radiolabeled with technetium-99m to prepare [99mTc]Tc-CN7DM. The six-coordinated structure of [99mTc]Tc-CN7DM was confirmed by the corresponding rhenium compound (Re-CN7DM). [99mTc]Tc-CN7DM was transported into cancer cells via GLUTs and may be trapped in the cancer cells by electrostatic attraction. The probe exhibited high uptake in tumors and low uptake in nontarget tissues in mice bearing different tumors, indicating that [99mTc]Tc-CN7DM exhibited promising potential for SPECT tumor imaging and warranted further clinical investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Radiopharmaceuticals of Ministry of Education, NMPA (National Medical Products Administration) Key Laboratory for Research and Evaluation of Radiopharmaceuticals, College of Chemistry, Beijing Normal U…
- Key Laboratory of Beam Technology of the Ministry of Education, School of Physics and Astronomy, Beijing Normal University, Beijing 100875, China.
- Department of Nuclear Technology and Application, China Institute of Atomic Energy, Beijing 102413, China.
ORCID-Profile: Qing Ruan, Junbo Zhang
Förderung
- Beijing Municipal Natural Science Foundation
- National Natural Science Foundation of China
- Beijing Nova Program
Zitieren
APA
Yin, G., Ruan, Q., Jiang, Y., Feng, J., Han, P., Wang, Q., Li, Z., & Zhang, J. (2024). Novel 99m Tc-Labeled Mannose Derivative as a Highly Promising Single Photon Emission Computed Tomography Probe for Tumor Imaging. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01425
Vancouver
Yin G, Ruan Q, Jiang Y, Feng J, Han P, Wang Q, et al. Novel 99m Tc-Labeled Mannose Derivative as a Highly Promising Single Photon Emission Computed Tomography Probe for Tumor Imaging. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01425
BibTeX
@article{Yin2024,
author = {Yin, Guangxing and Ruan, Qing and Jiang, Yuhao and Feng, Junhong and Han, Peiwen and Wang, Qianna and Li, Zuojie and Zhang, Junbo},
title = {Novel 99m Tc-Labeled Mannose Derivative as a Highly Promising Single Photon Emission Computed Tomography Probe for Tumor Imaging},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c01425}
}
EUVIMED